Communicable Diseases Intelligence Quarterly Report This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Australian Meningococcal Surveillance Programme, 1 July to 30 September 2015.
Authors: Lahra MM, Enriquez RP, Australian Meningococcal Surveillance Programme PMID: 26779740 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - January 20, 2016 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Australian Sentinel Practices Research Network, 1 July to 30 September 2015.
Authors: Chilver MB, Blakeley D, Stocks NP, Australian Sentinel Practices Research Network PMID: 26779741 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - January 20, 2016 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

HIV surveillance, 1 January to 31 March 2014.
Authors: Kirby Institute PMID: 26779742 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - January 20, 2016 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

HIV surveillance, 1 January to 31 March 2014.
Authors: Kirby Institute PMID: 26779743 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - January 20, 2016 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

HIV surveillance, 1 January to 31 March 2014.
Authors: Kirby Institute PMID: 26779744 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - January 20, 2016 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

HIV surveillance, 1 January to 31 March 2014.
Authors: Kirby Institute PMID: 26779745 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - January 20, 2016 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Medically-attended respiratory illnesses amongst pregnant women in Brisbane, Australia.
Authors: Rufus Ashiedu P, Andrews RM, Lambert SB, McHugh L, LeGros-Wilson S, Zenchyson J, Arnold D, Shevell C, O'Grady KA Abstract There are limited community-based data on the burden of influenza and influenza-like illnesses during pregnancy to inform disease surveillance and control. We aimed to determine the incidence of medically-attended respiratory illnesses (MARI) in pregnant women and the proportion of women who are tested for respiratory pathogens at these visits. We conducted a nested retrospective cohort study of a non-random sample of women aged 18 years or over who had a live birth in maternit...
Source: Communicable Diseases Intelligence Quarterly Report - December 3, 2015 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Notification and management of congenital syphilis in the Northern Territory 2009 to 2014.
CONCLUSIONS: Application of standard case definitions significantly increases the rate of congenital syphilis cases in the Northern Territory. Improved education regarding CDNA criteria for notification of congenital syphilis is necessary for clinicians and public health staff. Emerging evidence has supported the recent simplification of CDNA criteria for notification of congenital syphilis, effective 1 July 2015. Commun Dis Intell 2015;39(3):E323-E328. PMID: 26620345 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - December 3, 2015 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Pertussis immunisation in pregnancy: a summary of funded Australian state and territory programs.
This report of that meeting provides the first published comparison of these jurisdictional programs, which are of a broadly similar nature but with important differences. Monitoring and evaluation of the uptake, safety and impact of the current programs in Australia will be important to inform future policy decisions. Commun Dis Intell 2015;39(3):E329-E336. PMID: 26620346 [PubMed - in process] (Source: Communicable Diseases Intelligence Quarterly Report)
Source: Communicable Diseases Intelligence Quarterly Report - December 3, 2015 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Australian Rotavirus Surveillance Program annual report, 2014.
This report highlights the continued significance of G12P[8] strains as the major cause of disease in this population. The genotype distribution was slightly altered when the analysis was restricted to samples collected from children under 5 years of age, with G1P[8] being the dominant genotype (29%) followed by G12P[8] as the 2nd most common genotype (26%). Fluctuations in genotype distribution were also observed based on the vaccine type in use. Genotype G12P[8] was more common in states and territories using RotaTeq, while G1P[8] was more common in the locations using Rotarix. This survey highlights the yearly fluctuati...
Source: Communicable Diseases Intelligence Quarterly Report - December 3, 2015 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Australian Gonococcal Surveillance Programme annual report, 2014.
Authors: Lahra MM, Australian Gonococcal Surveillance Programme Abstract The Australian Gonococcal Surveillance Programme (AGSP) has continuously monitored antimicrobial resistance in clinical isolates of Neisseria gonorrhoeae from all states and territories since 1981. In 2014, 4,804 clinical isolates of gonococci from public and private sector sources were tested for in vitro antimicrobial susceptibility by standardised methods. Decreased susceptibility to ceftriaxone (MIC value 0.06-0.125 mg/L) was found nationally in 5.4% of isolates, a lower proportion than that reported in the AGSP 2013 annual report...
Source: Communicable Diseases Intelligence Quarterly Report - December 3, 2015 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Influenza epidemiology in adults admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN).
This report summarises the epidemiology of hospitalisations with laboratory-confirmed influenza during the 2014 influenza season. In this observational study, cases were defined as patients admitted to one of the sentinel hospitals with an acute respiratory illness with influenza confirmed by nucleic acid detection. During the period 3 April to 31 October 2014 (the 2014 influenza season), 1,692 adult patients (>16 years) were admitted with confirmed influenza to one of 15 of 17 FluCAN sentinel hospitals (excluding 2 paediatric hospitals). Of these, 47% were over 65 years of age, 10% were Indigenous Australians, 3.3% we...
Source: Communicable Diseases Intelligence Quarterly Report - December 3, 2015 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Flutracking weekly online community survey of influenza-like illness: 2013 and 2014.
This article reports on the 2013 and 2014 findings from Flutracking. From 2013 to 2014 there was a 14.0% increase in participants who completed at least 1 survey to 21,021 participants. By the end of the 2013 and 2014 seasons, respectively 59.7% and 59.1% of all participants had received the seasonal influenza vaccine. The 2013 Flutracking national ILI weekly incidence peaked in late August at 4.3% in the unvaccinated group, 1 week earlier than national counts of laboratory confirmed influenza. The 2014 Flutracking national ILI weekly incidence also peaked in late August at 4.7% in the unvaccinated group, in the same week ...
Source: Communicable Diseases Intelligence Quarterly Report - December 3, 2015 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Surveillance of adverse events following immunisation in Australia annual report, 2013.
This report summarises Australian passive surveillance data for adverse events following immunisation (AEFI) for 2013 reported to the Therapeutic Goods Administration (TGA) for 2013 and describes reporting trends over the 14-year period 1 January 2000 to 31 December 2013. There were 3,161 AEFI records for vaccines administered in 2013. This is an annual AEFI reporting rate of 13.9 per 100,000 population, the 2nd highest since 2000 and an increase of 59% compared with 2012 (1,994 AEFI records; 8.8 per 100,000 population). The increase was partly due to implementation of enhancements to vaccine safety reporting. This include...
Source: Communicable Diseases Intelligence Quarterly Report - December 3, 2015 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research

Australia's notifiable disease status, 2013: Annual report of the National Notifiable Diseases Surveillance System.
Authors: NNDSS Annual Report Writing Group Abstract In 2013, 65 diseases and conditions were nationally notifiable in Australia. States and territories reported a total of 224,434 notifications of communicable diseases to the National Notifiable Diseases Surveillance System, a decrease of 8% on the number of notifications in 2012. In 2013, the most frequently notified diseases were sexually transmissible infections (100,949 notifications, 45% of total notifications), vaccine preventable diseases (59,630 notifications, 26.6% of total notifications), and gastrointestinal diseases (32,536 notifications, 14.5%...
Source: Communicable Diseases Intelligence Quarterly Report - December 3, 2015 Category: Infectious Diseases Tags: Commun Dis Intell Q Rep Source Type: research